MyoKardia, Inc.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. With a focus on oncology, cardiovascular, immunoscience, and fibrosis, the company combines the resources of a large pharmaceutical with the agility of a biotech. It is committed to sustainability, health equity, and positive community impact, working responsibly to create a better future for patients and society.
Industries
Nr. of Employees
medium (51-250)
MyoKardia, Inc.
Rivergate / Gate 1 / 5th Floor Handelskai 92 A-1200 Vienna
Patents
Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof
US-11680050-B2
View Details
Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof
US-11680050-B2
View DetailsProducts
Universal patient language framework
A content development framework for translating complex medical information into clear, patient-facing language.
Clinical trial matching platform
Online platform to help patients and researchers find and connect for clinical studies.
MS&T sustainability improvement portal
Internal portal used to catalog sustainability projects, share learnings and quantify environmental impact of packaging and process changes.
Clinical-scale viral vector manufacturing facility
Facility capability for production of viral vectors to support clinical cell and gene therapy programs.
Radiopharmaceutical development platform
Acquired platform and capabilities for development and commercialization of radiopharmaceutical therapies and diagnostics.
Universal patient language framework
A content development framework for translating complex medical information into clear, patient-facing language.
Clinical trial matching platform
Online platform to help patients and researchers find and connect for clinical studies.
MS&T sustainability improvement portal
Internal portal used to catalog sustainability projects, share learnings and quantify environmental impact of packaging and process changes.
Clinical-scale viral vector manufacturing facility
Facility capability for production of viral vectors to support clinical cell and gene therapy programs.
Radiopharmaceutical development platform
Acquired platform and capabilities for development and commercialization of radiopharmaceutical therapies and diagnostics.
Services
Operational support for clinical trials including patient matching, recruitment and site engagement.
Telephone and web-based contact centers that provide medical information to healthcare professionals and collect adverse event and product quality reports.
Systems and programs for ongoing safety monitoring of marketed products, including literature surveillance for environmental risks and coordination of takeback programs.
Process development, packaging trials and cross-functional evaluation to improve manufacturing efficiency and reduce environmental footprint.
Programs for water reduction, smart metering, wastewater assessment and global site coordination to reduce resource use.
Development of plain-language educational materials and frameworks to improve patient understanding and health literacy.
Operational support for clinical trials including patient matching, recruitment and site engagement.
Telephone and web-based contact centers that provide medical information to healthcare professionals and collect adverse event and product quality reports.
Systems and programs for ongoing safety monitoring of marketed products, including literature surveillance for environmental risks and coordination of takeback programs.
Process development, packaging trials and cross-functional evaluation to improve manufacturing efficiency and reduce environmental footprint.
Programs for water reduction, smart metering, wastewater assessment and global site coordination to reduce resource use.
Development of plain-language educational materials and frameworks to improve patient understanding and health literacy.
Expertise Areas
- Clinical trial management and patient recruitment
- Translational medicine and biomarker-driven development
- Cell therapy development and manufacturing (including viral vector production and allogeneic approaches)
- Biologics and sterile manufacturing scale-up
Key Technologies
- Cell therapy platforms
- Viral vector manufacturing
- iPSC-derived allogeneic cell therapies
- Antibody–drug conjugates (ADC)
News & Updates
Bristol Myers Squibb was named on Fast Company's list for bringing COBENFY(TM) to market.
Bristol Myers Squibb was included in the list of companies with worker-focused policies supporting women.
The FDA approval of COBENFY(TM) was recognized with a 2025 BioNJ Innovator Award.
Bristol Myers Squibb was named a Military Friendly Top Ten Employer and Spouse Employer.
Bristol Myers Squibb was recognized as a Certified Age-Friendly Employer in the U.S.
COBENFY(TM) was named to TIME magazine’s 200 Best Inventions list.
Bristol Myers Squibb was named on Fast Company's list for bringing COBENFY(TM) to market.
Bristol Myers Squibb was included in the list of companies with worker-focused policies supporting women.
The FDA approval of COBENFY(TM) was recognized with a 2025 BioNJ Innovator Award.
Bristol Myers Squibb was named a Military Friendly Top Ten Employer and Spouse Employer.
Bristol Myers Squibb was recognized as a Certified Age-Friendly Employer in the U.S.
COBENFY(TM) was named to TIME magazine’s 200 Best Inventions list.